173 related articles for article (PubMed ID: 15649266)
1. Fel d 1-derived T cell peptide therapy induces recruitment of CD4+ CD25+; CD4+ interferon-gamma+ T helper type 1 cells to sites of allergen-induced late-phase skin reactions in cat-allergic subjects.
Alexander C; Ying S; B Kay A; Larché M
Clin Exp Allergy; 2005 Jan; 35(1):52-8. PubMed ID: 15649266
[TBL] [Abstract][Full Text] [Related]
2. Cat allergen peptide immunotherapy reduces CD4(+) T cell responses to cat allergen but does not alter suppression by CD4(+) CD25(+) T cells: a double-blind placebo-controlled study.
Smith TR; Alexander C; Kay AB; Larché M; Robinson DS
Allergy; 2004 Oct; 59(10):1097-101. PubMed ID: 15355469
[TBL] [Abstract][Full Text] [Related]
3. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.
Bellinghausen I; Metz G; Enk AH; Christmann S; Knop J; Saloga J
Eur J Immunol; 1997 May; 27(5):1131-9. PubMed ID: 9174602
[TBL] [Abstract][Full Text] [Related]
4. Proliferation and release of IL-5 and IFN-gamma by peripheral blood mononuclear cells from cat-allergic asthmatics and rhinitics, non-cat-allergic asthmatics, and normal controls to peptides derived from Fel d 1 chain 1.
Haselden BM; Syrigou E; Jones M; Huston D; Ichikawa K; Chapman MD; Kay AB; Larché M
J Allergy Clin Immunol; 2001 Sep; 108(3):349-56. PubMed ID: 11544452
[TBL] [Abstract][Full Text] [Related]
5. The effect of Fel d 1-derived T-cell peptides on upper and lower airway outcome measurements in cat-allergic subjects.
Alexander C; Tarzi M; Larché M; Kay AB
Allergy; 2005 Oct; 60(10):1269-74. PubMed ID: 16134993
[TBL] [Abstract][Full Text] [Related]
6. In vitro evidence of efficacy and safety of a polymerized cat dander extract for allergen immunotherapy.
Morales M; Gallego M; Iraola V; Taulés M; de Oliveira E; Moya R; Carnés J
BMC Immunol; 2017 Feb; 18(1):10. PubMed ID: 28235411
[TBL] [Abstract][Full Text] [Related]
7. Targeting Fel d 1 to FcgammaRI induces a novel variation of the T(H)2 response in subjects with cat allergy.
Hulse KE; Reefer AJ; Engelhard VH; Satinover SM; Patrie JT; Chapman MD; Woodfolk JA
J Allergy Clin Immunol; 2008 Mar; 121(3):756-762.e4. PubMed ID: 18086491
[TBL] [Abstract][Full Text] [Related]
8. A role for IL-10-mediated HLA-DR7-restricted T cell-dependent events in development of the modified Th2 response to cat allergen.
Reefer AJ; Carneiro RM; Custis NJ; Platts-Mills TA; Sung SS; Hammer J; Woodfolk JA
J Immunol; 2004 Mar; 172(5):2763-72. PubMed ID: 14978075
[TBL] [Abstract][Full Text] [Related]
9. Late asthmatic reactions provoked by intradermal injection of T-cell peptide epitopes are not associated with bronchial mucosal infiltration of eosinophils or T(H)2-type cells or with elevated concentrations of histamine or eicosanoids in bronchoalveolar fluid.
Haselden BM; Larché M; Meng Q; Shirley K; Dworski R; Kaplan AP; Bates C; Robinson DS; Ying S; Kay AB
J Allergy Clin Immunol; 2001 Sep; 108(3):394-401. PubMed ID: 11544459
[TBL] [Abstract][Full Text] [Related]
10. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W
J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125
[TBL] [Abstract][Full Text] [Related]
11. Induction of T 'regulatory' cells by standardized house dust mite immunotherapy: an increase in CD4+ CD25+ interleukin-10+ T cells expressing peripheral tissue trafficking markers.
Gardner LM; Thien FC; Douglass JA; Rolland JM; O'Hehir RE
Clin Exp Allergy; 2004 Aug; 34(8):1209-19. PubMed ID: 15298560
[TBL] [Abstract][Full Text] [Related]
12. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction.
Ying S; Kikuchi Y; Meng Q; Kay AB; Kaplan AP
J Allergy Clin Immunol; 2002 Apr; 109(4):694-700. PubMed ID: 11941321
[TBL] [Abstract][Full Text] [Related]
13. Regulatory activity of human CD4 CD25 T cells depends on allergen concentration, type of allergen and atopy status of the donor.
Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
Immunology; 2005 Sep; 116(1):103-11. PubMed ID: 16108822
[TBL] [Abstract][Full Text] [Related]
14. Modulation of CRTh2 expression on allergen-specific T cells following peptide immunotherapy.
Rudulier CD; Tonti E; James E; Kwok WW; Larché M
Allergy; 2019 Nov; 74(11):2157-2166. PubMed ID: 31077596
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract.
Ewbank PA; Murray J; Sanders K; Curran-Everett D; Dreskin S; Nelson HS
J Allergy Clin Immunol; 2003 Jan; 111(1):155-61. PubMed ID: 12532112
[TBL] [Abstract][Full Text] [Related]
16. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.
Varney VA; Hamid QA; Gaga M; Ying S; Jacobson M; Frew AJ; Kay AB; Durham SR
J Clin Invest; 1993 Aug; 92(2):644-51. PubMed ID: 8349803
[TBL] [Abstract][Full Text] [Related]
17. Immune regulation by intralymphatic immunotherapy with modular allergen translocation MAT vaccine.
Zaleska A; Eiwegger T; Soyer O; van de Veen W; Rhyner C; Soyka MB; Bekpen C; Demiröz D; Treis A; Söllner S; Palomares O; Kwok WW; Rose H; Senti G; Kündig TM; Ozoren N; Jutel M; Akdis CA; Crameri R; Akdis M
Allergy; 2014 Sep; 69(9):1162-70. PubMed ID: 24934402
[TBL] [Abstract][Full Text] [Related]
18. Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects.
Oldfield WL; Kay AB; Larché M
J Immunol; 2001 Aug; 167(3):1734-9. PubMed ID: 11466398
[TBL] [Abstract][Full Text] [Related]
19. Ultra-rush venom immunotherapy induces differential T cell activation and regulatory patterns according to the severity of allergy.
Mamessier E; Birnbaum J; Dupuy P; Vervloet D; Magnan A
Clin Exp Allergy; 2006 Jun; 36(6):704-13. PubMed ID: 16776670
[TBL] [Abstract][Full Text] [Related]
20. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses.
Trujillo-Vargas CM; Mayer KD; Bickert T; Palmetshofer A; Grunewald S; Ramirez-Pineda JR; Polte T; Hansen G; Wohlleben G; Erb KJ
Clin Exp Allergy; 2005 Aug; 35(8):1003-13. PubMed ID: 16120081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
